Drug: irinotecan hcl Quarter: 2016Q3
Total Records: 86 Number of Pages: 5
DRUGNAME | PT | EventCount |
---|---|---|
IRINOTECAN HCL | Cholinergic syndrome | 1 |
IRINOTECAN HCL | Chromaturia | 1 |
IRINOTECAN HCL | Chronic obstructive pulmonary disease | 1 |
IRINOTECAN HCL | Colon cancer metastatic | 1 |
IRINOTECAN HCL | Cutaneous tuberculosis | 1 |
IRINOTECAN HCL | Diarrhoea haemorrhagic | 1 |
IRINOTECAN HCL | Diplopia | 1 |
IRINOTECAN HCL | Disease progression | 1 |
IRINOTECAN HCL | Dysphonia | 1 |
IRINOTECAN HCL | Dyspnoea | 1 |
IRINOTECAN HCL | Dyspnoea exertional | 1 |
IRINOTECAN HCL | Dysuria | 1 |
IRINOTECAN HCL | Endometrial disorder | 1 |
IRINOTECAN HCL | Failure to anastomose | 1 |
IRINOTECAN HCL | Feeding intolerance | 1 |
IRINOTECAN HCL | Hepatotoxicity | 1 |
IRINOTECAN HCL | Hyperhidrosis | 1 |
IRINOTECAN HCL | Hypertensive heart disease | 1 |
IRINOTECAN HCL | Hypoaesthesia | 1 |
IRINOTECAN HCL | Hypokalaemia | 1 |
Total Records: 86 Number of Pages: 5